TrialAmerican journal of hematology2022

Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open-label study.

David J Kuter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.